Request Deal Involvement
Bavarian Nordic to acquire the travel vaccine portfolio of Emergent BioSolutions for $380m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Cooley
debt providers
Nordea Bank
financial advisors
Nordea Bank
financial advisors
Morgan Stanley
debt providers
Danske Bank
pr advisors
Joele Frank
financial advisors
Lincoln International
legal advisors to financial advisors
Gibson Dunn & Crutcher
legal advisors
Lenz & Staehelin
or
Principals
bidder
BAVARIAN NORDIC
vendor
EMERGENT BIOSOLUTIONS INC
target
EMERGENT BIOSOLUTIONS (TRAVEL VACCINES PORTFOLIOS)
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite